Abbott | أرباح التشغيل



Operating Profit تغيير تاريخ
Abbott USD 1.66B 253M 2025-03
Agilent USD 376M 32M 2025-01
AtriCure USD -5954000 8.57M 2025-03
Baxter International USD -435000000 590M 2024-12
Becton, Dickinson and Co. USD 453M 195M 2024-12
Bio-Rad Laboratories USD 58.4M 6.07M 2024-12
Boston Scientific USD 921M 246M 2025-03
Cooper Companies USD 182M 16.4M 2025-01
Danaher USD 1.28B 142M 2025-03
Dexcom USD 188.9M 36.9M 2024-12
Edwards Lifesciences USD 394.8M 82.2M 2025-03
Globus Medical USD 60.27M 12.18M 2024-12
Hologic USD 229.8M 200K 2024-12
Insulet USD 109.3M 21.2M 2024-12
Integra LifeSciences USD 35.23M 43.36M 2024-12
Intuitive Surgical USD 578.1M 156.8M 2025-03
J&J USD 13.63B 9.74B 2025-03
Masimo USD -359100000 389.2M 2024-12
Medtronic USD 1.65B 51M 2025-01
Merit Medical Systems USD 41.03M 4.47M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
Smith & Nephew USD 329M 1000K 2024-12
Solventum Corp 136M 139M 2024-12
Stryker USD 581M 504M 2024-12
Tandem Diabetes Care USD -120878000 120.3M 2025-03
Teleflex USD 130.32M 240.71M 2025-03
Terumo JPY 45.78B 2.7B 2024-12
Thermo Fisher Scientific USD 1.72B 300M 2025-03
Zimmer Biomet Holdings USD 389M 109.5M 2024-12



Abbott أرباح التشغيل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.